0

Pediatric Stroke Clinical Trial

Pediatric Stroke Clinical Trial

By The Cord Blood Registry

Stroke occurs when blood flow is interrupted to part of the brain, leading to the destruction of brain cells. The risk of a stroke in children is greatest in the first year of life, and peaks during the perinatal period, roughly the weeks before and immediately after birth. Now, families who have saved their children’s cord blood with Cord Blood Registry® have access to a new use for the stem cells. A new clinical trial at the Florida Hospital for Children will investigate using a child’s own cord blood stem cells as treatment after a pediatric stroke.

Recruitment is underway to enroll 10 children between the ages of 6 weeks and 6 years who have experienced a stroke in utero or immediately after birth, and who have a CBR-processed cord blood unit which was collected at birth. Subjects will first receive a baseline neurologic evaluation which includes brain imaging, evaluation of epilepsy, nerve impulses, and bladder control issues, which will help assess the overall severity of the stroke’s impact prior to treatment. After this evaluation is complete, eligible patients will receive a single autologous stem cell infusion, with follow-up testing to occur after six and 12 months.

Read the full story.

Rate this post

FREE MEDICAL AND LEGAL RESOURCES

The Cerebral Palsy Survival Guide is a free, state-specific resource list for everything from everyday activities to emergency situations.

BI-WEEKLY E-NEWSLETTER SIGN-UP

Sign up for our e-newsletter to receive the latest in CP news, resources and

LATEST BLOG POSTS

Camp Smiles – One Year Later!

By Anita Howell Watch more CPFN TV One year, dozens of hurdles, a couple of panic attacks, a few doubts and thousand of smiles later, we have an amazing annual…

Read more

Why I View My Cerebral Palsy as a Blessing

By Ashley Mohesky Cerebral palsy (CP) is a neurological disorder that prevents the brain from communicating to the muscles. There are different types of cerebral palsy, but everyone with the…

Read more